Towards Healthcare

News

Your Daily Gateway to Essential News in Healthcare, Science, Technology and Business Worldwide

A New Era in Men’s Vitality: GNC Unveils Exclusive Formulas
17 February 2026

A New Era in Men’s Vitality: GNC Unveils Exclusive Formulas

GNC on Feb 11, 2026, became a partner with High Level Science, with high quality supplement company, started with two celebrity names, Ashley Parker Angel and heart doctor Dr. David Rizik. Together they are bringing two of the high-level science’s popular products to GNC stores. High Level Man...

Optune Pax® Received Permission to Heal Generally Advanced Pancreatic Cancer
16 February 2026

Optune Pax® Received Permission to Heal Generally Advanced Pancreatic Cancer

Introduction Novocure is a leading oncology company believing in giving more reasons to release the stress of aggressive cancers via (Tumor Treating) TTFields therapy. The company utilize electric fields and markets Optune Lua and Optune for pleural mesothelioma and glioblastoma. Novocure tech-inte...

Hengrui and Kailera cleared their path for a new victory
13 February 2026

Hengrui and Kailera cleared their path for a new victory

Introduction Kailera Therapeutics is a leading clinically inspired biopharmaceutical company with its footprint in the healthcare sector since October 2024. The company is dedicated towards increasing the number of future effective therapies in its portfolio for suitable metabolic conditions and ob...

Is Ultragenyx’s Gene Therapy close to the Win?
12 February 2026

Is Ultragenyx’s Gene Therapy close to the Win?

Introduction Ultragenyx Pharmaceuticals is a well-known biopharmaceutical company, popular for its innovative therapies for debilitating genetic, rare and ultra-rare conditions. From the company’s homeland, Novato, California, the company use numerous modalities like mRNA, small molecules and...

Natera’s EDEN study on board
11 February 2026

Natera’s EDEN study on board

Introduction Natera, Inc., a leading clinical genetic testing company aiming on technologies for better health and organs of women. Since 2003, the company has dedicated its operations to an intensified molecular diagnostics like Panorama, Prospera and Signatera. The company’s precision in th...

CaseBioscience®’s two solutions are ready to contribute to Cell Therapy in the future
11 February 2026

CaseBioscience®’s two solutions are ready to contribute to Cell Therapy in the future

Introduction CaseBioscience®, a registered biotechnology company, is a scholar in advanced media, biopreservation solutions and cGMP-compliant mainly for cell therapy, IVF/ART, regenerative medicine and cell therapy. The company continues its business through its Stem cell Research and Assisted...

The FDA considered Pfizer’s review of sBLA in the first place
11 February 2026

The FDA considered Pfizer’s review of sBLA in the first place

Introduction Pfizer Inc., a popular multinational biopharmaceutical company with its origins in New York City, aims to discover appropriate vaccines and innovative drugs for immunology, inflammation, and oncology. Pfizer’s significant and most commercialised products include Advil, COVID-19 a...

Akeso’s one more Breakthrough Therapy Designation win
10 February 2026

Akeso’s one more Breakthrough Therapy Designation win

Introduction Akeso, Inc. is a leading biopharmaceutical company, popular for its full-fledged operation of establishing, manufacturing and marketing effective and creative antibody drugs for conditions like metabolic, immunology and oncology. Along with its exclusive Tetrabody bispecific antibody p...

Denali’s progress reports to heal Lysosomal Storage Disorders
10 February 2026

Denali’s progress reports to heal Lysosomal Storage Disorders

Introduction Denali Therapeutics is a biotechnology company built on the promise to establish core treatments for lysosomal storage disorders and neurodegenerative diseases. To present thorough and most worthy results, the company use exclusive TransportVehicle™ platform to ease therapeutic m...

Cheers to Balt for its PMA of the Squid™ liquid embolic agent
09 February 2026

Cheers to Balt for its PMA of the Squid™ liquid embolic agent

Introduction Balt Inc. is a medical device manufacturer that has given robust coils, catheters and stents products to the healthcare sector. With a total 950 workforce the company aims for interventional neurovascular and neuroradiology solutions. Balt met expansion for the first time after Bridgep...